Gilead Sciences

Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus
NASDAQ
Tue, 01/12/21 - 11:01 am
Gilead Sciences
Vir Biotechnology
hepatitis B
clinical trials
Oxford BioTherapeutics to research cell therapies for Gilead’s Kite
Pharmaforum
Thu, 01/7/21 - 11:28 am
Kite Pharma
Gilead Sciences
Oxford BioTherapeutics
solid tumors
blood cancer
cell therapy
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Fierce Pharma
Mon, 01/4/21 - 11:04 pm
drug pricing
Pfizer
AbbVie
Teva Pharmaceutical
Sanofi
Gilead Sciences
Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?
Fierce Biotech
Sun, 01/3/21 - 04:29 pm
China
COVID-19
Gilead Sciences
remdesivir
Folotyn
Acrotech Biopharma
Gilead latest pharma to join 2020 trend donating money and amping efforts to fight health inequality
Fierce Pharma
Tue, 12/29/20 - 11:04 am
Gilead Sciences
racial disparity
Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches
Fierce Pharma
Wed, 12/23/20 - 10:51 am
pharma marketing
drug pricing
COVID-19
pandemic
remdesivir
Gilead Sciences
HIV
PrEP
Pfizer
Where Will Gilead Sciences Be in 1 Year?
Motley Fool
Wed, 12/23/20 - 10:42 am
Gilead Sciences
Veklury
remdesivir
COVID-19
The top 5 pharma M&A deals of 2020
Pharmaforum
Mon, 12/21/20 - 11:07 am
M&A
AstraZeneca
Alexion
Gilead Sciences
Immunomedics
Forty Seven
JNJ
Momenta
Sanofi
Principia Biopharma
Gilead downsizes multibillion-dollar deal once at center of CEO's rebuild
Bizjournals
Tue, 12/15/20 - 08:31 pm
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
inflammatory bowel disease
Gilead inks a billion-dollar deal for a hepatitis drug
BioPharma Dive
Thu, 12/10/20 - 10:47 am
Gilead Sciences
Myr Pharmaceuticals
hepatitis D
M&A
ASH: Gilead's CAR-T med Yescarta shows promise earlier in lymphoma therapy
Fierce Pharma
Tue, 12/8/20 - 12:07 am
Gilead Sciences
Kite Pharma
Yescarta
diffuse large B-cell lymphoma
clinical trials
WHO's decision to reject remdesivir based on flawed study, health experts say
Beckers Hospital Review
Thu, 12/3/20 - 10:44 pm
WHO
Gilead Sciences
remdesivir
COVID-19
Gilead's New CEO Is Going All-In on Acquisitions
Motley Fool
Sun, 11/29/20 - 02:23 pm
Gilead Sciences
M&A
Daniel O'Day
Pharma CEOs
Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
Motley Fool
Sun, 11/29/20 - 02:20 pm
Gilead Sciences
COVID-19
remdesivir
How Gilead finally spent its money
BioPharma Dive
Tue, 11/24/20 - 10:28 am
Gilead Sciences
cancer
oncology
WHO group recommends against using remdesivir to treat hospitalized Covid-19 patients
Stat
Thu, 11/19/20 - 08:31 pm
WHO
Gilead Sciences
remdesivir
COVID-19
Veklury
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
Pharmaforum
Thu, 11/19/20 - 10:18 am
Gilead Sciences
lenacapavir
HIV
Gilead and Novo plot next steps after trial data from NASH combo
Pharmaforum
Mon, 11/16/20 - 10:19 am
Gilead Sciences
Novo Nordisk
NASH
clinical trials
semaglutide
cilofexor
firsocostat
COVID-19 tracker: Melatonin emerges as promising COVID treatment; Warp Speed chief Slaoui seeks Trump's OK to brief Biden team
Fierce Pharma
Sun, 11/15/20 - 04:40 pm
COVID-19
pandemic
Operation Warp Speed
vaccines
Moncef Slaoui
melatonin
Europe
Gilead Sciences
Veklury

Pages